TrialOphthalmology2026

Adalimumab versus Conventional Immunosuppression for Uveitis (ADVISE) Trial.

Adalimumab versus Conventional Immunosuppression for Uveitis Trial Research Group et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.